Literature DB >> 19552233

An intervention to improve cancer patients' understanding of early-phase clinical trials.

Nancy E Kass1, Jeremy Sugarman, Amy M Medley, Linda A Fogarty, Holly A Taylor, Christopher K Daugherty, Mark R Emerson, Steven N Goodman, Fay J Hlubocky, Herbert I Hurwitz, Michael Carducci, Annallys Goodwin-Landher.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19552233      PMCID： PMC2872090     

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  41 in total

1.  Can the written information to research subjects be improved?--an empirical study.

Authors:  E Bjørn; P Rossel; S Holm
Journal:  J Med Ethics       Date:  1999-06       Impact factor: 2.903

2.  False hopes and best data: consent to research and the therapeutic misconception.

Authors:  P S Appelbaum; L H Roth; C W Lidz; P Benson; W Winslade
Journal:  Hastings Cent Rep       Date:  1987-04       Impact factor: 2.683

3.  Trust, The fragile foundation of contemporary biomedical research.

Authors:  N E Kass; J Sugarman; R Faden; M Schoch-Spana
Journal:  Hastings Cent Rep       Date:  1996 Sep-Oct       Impact factor: 2.683

4.  Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Authors:  E J Robinson; C E P Kerr; A J Stevens; R J Lilford; D A Braunholtz; S J Edwards; S R Beck; M G Rowley
Journal:  Health Technol Assess       Date:  2005-03       Impact factor: 4.014

5.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Authors:  Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

6.  Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

Authors:  Thomas G Roberts; Bernardo H Goulart; Lee Squitieri; Sarah C Stallings; Elkan F Halpern; Bruce A Chabner; G Scott Gazelle; Stan N Finkelstein; Jeffrey W Clark
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

7.  The effectiveness of patient verbalization on informed consent.

Authors:  V Wadey; C Frank
Journal:  Can J Surg       Date:  1997-04       Impact factor: 2.089

8.  Risks and benefits of phase 1 oncology trials, 1991 through 2002.

Authors:  Elizabeth Horstmann; Mary S McCabe; Louise Grochow; Seiichiro Yamamoto; Larry Rubinstein; Troy Budd; Dale Shoemaker; Ezekiel J Emanuel; Christine Grady
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

9.  Informed consent: assessment of comprehension.

Authors:  D A Wirshing; W C Wirshing; S R Marder; R P Liberman; J Mintz
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

10.  Descriptions of benefits and risks in consent forms for phase 1 oncology trials.

Authors:  Sam Horng; Ezekiel J Emanuel; Benjamin Wilfond; Jonathan Rackoff; Karen Martz; Christine Grady
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245
View more
  31 in total

1.  "Entering a Clinical Trial: Is it Right for You?": a randomized study of The Clinical Trials Video and its impact on the informed consent process.

Authors:  Brianna Hoffner; Susan Bauer-Wu; Suzanne Hitchcock-Bryan; Mark Powell; Andrew Wolanski; Steven Joffe
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

2.  Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site.

Authors:  Sarah E Van Pilsum Rasmussen; Shanti Seaman; Diane Brown; Niraj Desai; Mark Sulkowski; Dorry L Segev; Christine M Durand; Jeremy Sugarman
Journal:  AJOB Empir Bioeth       Date:  2019-10-16

3.  Palliative Care and Phase 1 Trials: Intervention to Improve Quality of Life and Provide Education
.

Authors:  Betty R Ferrell; Vincent Chung; Marianna Koczywas; Anna Cathy Williams; Denise Gallagher; Patricia Fischer; Thomas J Smith
Journal:  Clin J Oncol Nurs       Date:  2017-08-01       Impact factor: 1.027

4.  American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors:  Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

5.  Patient preferences toward an interactive e-consent application for research using electronic health records.

Authors:  Christopher A Harle; Elizabeth H Golembiewski; Kiarash P Rahmanian; Janice L Krieger; Dorothy Hagmajer; Arch G Mainous; Ray E Moseley
Journal:  J Am Med Inform Assoc       Date:  2018-03-01       Impact factor: 4.497

6.  Improving informed consent: Stakeholder views.

Authors:  Emily E Anderson; Susan B Newman; Alicia K Matthews
Journal:  AJOB Empir Bioeth       Date:  2017-08-02

7.  Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.

Authors:  Lauren M Hamel; Louis A Penner; Terrance L Albrecht; Elisabeth Heath; Clement K Gwede; Susan Eggly
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

8.  Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials.

Authors:  Katherine E Reeder-Hayes; Megan C Roberts; Gail E Henderson; Elizabeth C Dees
Journal:  J Oncol Pract       Date:  2017-08-24       Impact factor: 3.840

9.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

Review 10.  Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009.

Authors:  Valerie A Jenkins; John L Anderson; Lesley J Fallowfield
Journal:  Support Care Cancer       Date:  2010-03-04       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.